NCT03525912View on ClinicalTrials.gov

Neuropsychiatric and Cardiovascular Side Effects in Ketamine Analgesic Infusions

NACompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

March 31, 2018

Study Completion Date

November 14, 2018

Conditions
Pain, PostoperativeKetamine Adverse Reaction
Interventions
DRUG

Ketamine

continuous infusion of low dose ketamine for postoperative pain

Trial Locations (1)

Unknown

hospital universitario San Vicente Fundacion, Medellín

All Listed Sponsors
lead

Universidad de Antioquia

OTHER

NCT03525912 - Neuropsychiatric and Cardiovascular Side Effects in Ketamine Analgesic Infusions | Biotech Hunter | Biotech Hunter